CLINICAL TRIAL AGREEMENTClinical Trial Agreement • February 14th, 2019
Contract Type FiledFebruary 14th, 2019WHEREAS, Sponsor, a research-driven pharmaceutical company, is sponsoring and conducting a clinical trial of Dabigatran etexilate (“Investigational Product”) according to the Clinical Trial Protocol for BI Trial No. 1160.108 including all documents attached thereto and referenced therein (“Protocol”) entitled “„Open label, single arm safety prospective cohort study of dabigatran etexilate for secondary prevention of venous thromboembolism in children from 0 to less than 18 years” as amended (“Trial”), incorporated herein by reference and provided to Provider and Investigator by the Sponsor under separate cover in the regulatory document package,